EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma

Xiaofeng Li, Chunwei Xu iD, Yonghua Min, Zhanqiang Zhai, Youcai Zhu iD

The Clinical Respiratory Journal · 2023

DOI: 10.1111/crj.13723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2023. Verfasst von Xiaofeng Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxin…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan Project of Jiaxing (Science and Technology Innovation Research for Livelihood).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung adenocarcinoma (LUAD) is one of the most common subtypes of lung cancer. Finding prognostic biomarkers is helpful in stratifying LUAD patients with different prognosis.

Methods

We explored the correlation of LUAD prognosis and genes associated with chemotherapy in LUAD and obtained data of LUAD patients from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Drug sensitivity data were acquired from the Genomics of Drug Sensitivity in Cancer (GDSC) database. Differential and enrichment analyses were used to screen the target genes utilizing limma and “clusterProfiler” packages. Then univariate and LASSO Cox analyses were used to select the prognosis‐related genes. Survival analysis was used to estimate the overall survival (OS) of different groups.

Results

Twenty‐three differentially expressed genes (DEGs) were screened between LUAD samples and healthy samples, and BTK , FGFR2 , PIM2 , CHEK1 , and CDK1 were selected to construct a prognostic signature. The OS of patients in the high‐risk group (risk score higher than 0.69) was worse than that in the low‐risk group (risk score lower than 0.69).

Conclusion

The risk score model constructed by five genes is a potential prognostic biomarker for LUAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsHumansPrognosisDatabases, FactualHealth Status

Stichwörter der Autor:innen

Gene Expression Omnibus (GEO)chemotherapylung adenocarcinomarisk score

Autor:innen und Institutionen

  • Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.

ORCID-Profile: Chunwei Xu, Youcai Zhu

Förderung

  • Science and Technology Plan Project of Jiaxing (Science and Technology Innovation Research for Livelihood)

Zitieren

APA

Li, X., Xu, C., Min, Y., Zhai, Z., & Zhu, Y. (2023). A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.13723

Vancouver

Li X, Xu C, Min Y, Zhai Z, Zhu Y. A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma. The Clinical Respiratory Journal. 2023. doi:10.1111/crj.13723

BibTeX
@article{Li2023,
  author = {Li, Xiaofeng and Xu, Chunwei and Min, Yonghua and Zhai, Zhanqiang and Zhu, Youcai},
  title = {A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma},
  journal = {The Clinical Respiratory Journal},
  year = {2023},
  doi = {10.1111/crj.13723}
}
Kostenlos starten →